Roswell Park Cancer Institute Corporation
This role supports the development, optimization, and transfer of GMP-compliant CAR T-cell manufacturing processes from leukapheresis material through final product cryopreservation. The position involves executing hands-on cell therapy process development activities using automated and semi-automated manufacturing platforms. It also includes performing laboratory studies to evaluate process performance and conducting analytical testing to assess cell phenotype, viability, potency, and function.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roswell Park Cancer Institute Corporation.
4% above the average for this role
CAR-T Aseptic Manufacturing Operator
Johnson & Johnson Medical Korea Limited
Cell Production Specialist
AstraZeneca
Associate, QC Analytical, Cell Therapy
Bristol Myers Squibb
Cell Therapy Specialist II (26101-B-683-MFG)
Arsenal Biosciences
Process Engineer, Cell Therapy Process Development
AstraZeneca
Associate Scientist (Cell Therapy)
Dawar Consulting